At Julius Clinical, we are proud to announce the first formal meeting of our Dementia Scientific Advisory Board (SAB) with Prof. Philip Scheltens and Prof. John Harrison—a major milestone in our commitment to advancing dementia research and clin...
From being a largely unknown pathogen, Respiratory Syncytial Virus (RSV) is now almost a household word – and a fearful one for families with infants and young children at risk. But new solutions, such as long-acting monoclonal antibodies (mAbs)...
At Julius Clinical, we are collaborating with Esperion to dive deeper into the findings of the CLEAR trial outcomes. Our focus? Investigating the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and cardiovascu...
Zeist, Netherlands, April 22, 2024 — We proudly welcome Stefan Timmerman as our new Chief Financial Officer (CFO), effective April 1st, following up Eelco Brouwer, who played a crucial role in the completion of the Ampersand transaction last yea...
Zeist, Netherlands, April 5, 2024 — We’re proud to announce the appointment of Ricard Quingles Blasi as our new Chief Business Officer (CBO). With over 25 years of dynamic leadership experience, Ricard Quingles Blasi brings a wealth of strate...
On January 19, at 16.30 CET, we will present the webinar: Improving ALS Trial Delivery Through Insights from Patient and Industry ExperienceWhat You’ll LearnPatient- and Industry-Informed Insights Top patient-experience pitfalls obs...
On June 30, at 16.00 CEST, we will present the webinar: Boosting patient enrolment and retention in clinical trials: Expert Insights & TipsJoin us for an interactive discussion with experts who will draw upon recent cardiology and neurolog...
On April 10th, 2025, we will organise the webinar: Real-World Evidence in Vaccine Safety: Methods, Challenges, and Opportunities in Multi-Database Studies Why Attend?Expert Insights: Learn from leading professionals in vaccine epidemiolog...
How early can you detect whether a treatment is working in dementia trials, and what if you didn’t have to wait for traditional endpoints? Electroencephalography (EEG) is gaining momentum as a powerful tool to capture real-time changes in brain...
On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics:A...
"*" indicates required fields
"*" indicates required fields
